Male anti-fertility agents

a technology of anti-fertility agents and male mammals, which is applied in the direction of biocide, drug compositions, peptide/protein ingredients, etc., can solve the problems of 100% effective, health risks of continued long-term use of contraceptive hormones, and increased risk of certain forms of cancer

Inactive Publication Date: 2007-03-08
KLEIN ELLIOTT S +2
View PDF14 Cites 61 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0021] It has been known for some time that among the various results of a severe vitamin A (retinol) deficiency in mammals is sterility and blindness. See Eskild W. & Hansson. V., Vitamin A Functions in the Reproductive Organs in Vitamin A in Health and Disease 531 (Blomhoff, R. ed., 1994) (hereinafter Eskild). A complete deficiency in retinoids is fatal. Administration of retinoic acid in the absence of retinol can alleviate many of the symptoms of vitamin A deficiency, giving rise to blind and sterile animals that remain otherwise healthy.

Problems solved by technology

However, in recent years questions have arisen about the health risks involved in continued long term use of contraceptive hormones.
There have been reports of increased risk of certain forms of cancer, such as breast and cervical cancer, though the use of the Pill.
Surgical sterilization, whether through tubal ligation or vasectomy, is nearly 100% effective, but is only sometimes reversible.
Condoms, made of either synthetic polymer materials or animal skin, are less effective than birth control pills and their effectiveness is further subject to subversion through the possibility that small breaks may be present, permitting leakage of semen.
Additionally, the use of a condom requires the affirmative action of the male, usually immediately prior to the initiation of sexual intercourse and some men report a loss of sensation through the use of condoms.
Hence, subject non-compliance is also an issue in the use of condoms.
Side effects may be similar to those involved in the use of birth control pills, and include a risk of developing ovarian cysts.
Additionally, while the implant can be removed, the procedure is difficult even for skilled surgeons due to the formation of scar tissue around the implant.
Depending on the design, the devices appear to interfere with sperm motility or the implantation of the fertilized egg in the uterine wall.
Side effects can include cramps, backache, spotting, or heavy periods, and women may have an increased risk of ectopic pregnancy or infertility.
IUDs are usually not recommended for women who have not had children or who think they will have children in the future due to these latter risks.
The user can insert them as long as a number of hours before sexual intercourse, and the effects are temporary; if pregnancy is subsequently desired, the woman can discontinue their use with a concomitant return of fertility.
As mentioned above, the former of these methods is irreversible and the latter is neither inherently as effective as other methods, nor is compliance as high.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Male anti-fertility agents
  • Male anti-fertility agents
  • Male anti-fertility agents

Examples

Experimental program
Comparison scheme
Effect test

example 1

Oral Treatment of Spague-Dawley Rats with AGN 194310

[0152] Ninety-eight male and ninety-eight female Sprague-Dawley (Crl:CD®(SD) IGS BR) Charles River, Hollister, Calif. 95023) rats, approximately 8 to 10 weeks old, were used for the study. The rats were divided into the following groups: non-treated control, vehicle control, 0.005 mg / kg / day, 0.015 mg / kg / day and 0.15 mg / kg / day AGN 194310. AGN 194310 has the following chemical structure:

This compound, 4-[[4-(4-ethylphenyl)-2,2-dimethyl-(2H)-thiochromen-6-yl]-ethynyl]-benzoic acid, may be synthesized using conventional organic synthetic means. The following reaction scheme is Applicants' currently preferred method of making this compound.

[0153] Step 1: A heavy-walled screw cap tube was charged with 3-methyl-2-butenoic acid (13.86 g, 138.4 mmol), 4-methoxy thiophenol (20.0 g, 138.4 mmol), and piperidine (3.45 g, 41.6 mmol). This mixture was heated to 105° C. for 32 hours, cooled to room temperature and dissolved in EtOAc (700 mL)....

example 2

Topical Treatment of Spague-Dawley Rats with AGN 194310

[0188] An experiment was conducted in a manner substantially similar to that described in Example 1, with the following differences. Twenty-nine male and twenty-nine female Sprague-Dawley rats, approximately 7 weeks old were used for the study. Five rats / sex / group were designated as Main Study animals: (vehicle control, 0.025 mg / kg / day AGN 194310, and 0.25 mg / kg / day AGN 194310), and 7 / sex / group designated as toxicokinetic satellite animals (0.025 mg / kg / day AGN 194310 and 0.25 mg / kg / day AGN 194310). No “vehicle alone” control group was made for the toxicokinetic satellite animals. In this study there was no Recovery group.

[0189] The animals' backs were maintained shaven during the course of the study for application of the topical cream. The animals were treated daily with a topical formulation containing either AGN 194310 vehicle cream alone, 0.01% (w / w) AGN 194310 in the same vehicle cream, or 0.1% (w / w) AGN 194310 in the sam...

example 3

Reversibility of Spermatogenic Arrest

[0195] This experiment was conducted in a manner substantially similar to that of Example 1. Groups of male Sprague Dawley rats were treated orally for 4 weeks with either 0, 0.075, or 0.150 mg / kg / day of AGN 194310. Three to six animals from each group were sacrificed after 2 weeks of treatment, 6 animals from each group were sacrificed following 4 weeks of treatment and 6 animals from each group were sacrificed after 18-23 weeks of subsequent recovery after cessation of treatment. Histological and pathological examinations were done of the sacrificed animals, as in Example 1. Additionally, the animals in the 23 week recovery group were mated to normal, untreated female Sprague Dawley rats before being sacrificed to assess the reproductive function.

[0196] As in the previous examples, the control group of rats (no drug) displayed no abnormal histological or biochemical differences during the time course of the experiment, except for a single ind...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
Login to view more

Abstract

Methods and compositions for inhibiting or preventing spermatogenesis in a male mammal. Also disclosed are compounds and formulations for use in such methods.

Description

RELATED APPLICATIONS [0001] This application is a continuation of U.S. application Ser. No. 10 / 304,665, filed Nov. 25, 2002, which is a continuation of U.S. application Ser. No. 09 / 591,253, filed on Jun. 9, 2000, now U.S. Pat. No. 6,521,641, which is a continuation-in-part of U.S. application Ser. No. 09 / 405,748, filed Sep. 27, 1999, now abandoned, which claims the benefit of Provisional Application No. 60 / 103,507, filed Apr. 14, 1998. [0002] The entire teachings of the above application(s) are incorporated herein by reference.FIELD OF THE INVENTION [0003] The present invention concerns methods and compositions for inhibiting or blocking fertility in a male mammal by the administration of a retinoid or retinoid derivative that is able to act as an antagonist or inverse agonist of a retinoic acid receptor (RAR). The effect is reversible upon cessation of treatment with the RAR antagonist or inverse agonist. BACKGROUND OF THE INVENTION [0004] The prevention of unplanned pregnancy in h...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K31/695A61K31/47A61K31/382A61K31/353A61K31/195A61K31/00A61K31/192A61K31/196A61K31/203A61P15/16
CPCA61K31/00A61K31/192A61K31/195A61K31/196Y10S514/841A61K31/353A61K31/382A61K31/47A61K31/695A61K31/203A61P15/16
Inventor KLEIN, ELLIOTT S.YUAN, YANG-DARCHANDRARATNA, ROSHANTHA A.
Owner KLEIN ELLIOTT S
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products